[Nizatidine: a meta-analytical study].
The medline database was applied to search all randomized clinical trials published from 1986 to 1992 concerning the use of Nizatidine, a powerful H2-antagonist, versus other treatments, including placebo, in the treatment of duodenal ulcer disease. Therapeutic efficacy of nizatidine is comparable to that of other H2-antagonists; with the use of meta-analysis, no significant differences were demonstrated, both in acute and long-term treatment of duodenal ulcer between nizatidine and ranitidine, but untoward side effects were less frequent with nizatidine than with ranitidine.
di Ciommo
V
V
Ospedale Bambino Gesù di Palidoro (RM), Servizio di Medicina.
Ferrario
F
F
D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004381:Duodenal Ulcer / Q000188:drug therapy; D006801:Humans; D008523:MEDLARS; D016567:Nizatidine / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D011899:Ranitidine / Q000009:adverse effects
D011899:Ranitidine; D016567:Nizatidine
La nizatidina: uno studio metanalitico.